Kala Pharmaceuticals, Inc.
SEC CIK 1479419 · KALA · last insider filing 2026-02-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Posen Hillel D. | Director | filed 2026 - 2026 |
| Minkowitz Avraham | Director · Chief Executive Officer | filed 2026 - 2026 |
| Colman Yonatan C. | Director | filed 2026 - 2026 |
| Berger Chaim D. | Director | filed 2026 - 2026 |
| Purdy Brendan P. | Director | filed 2026 - 2026 |
| Lazar David E. | Director · Chief Executive Officer | filed 2025 - 2025 |
| Iwicki Mark T | Director · Chief Executive Officer | filed 2017 - 2025 |
| Bazemore Todd | Director · SEE REMARKS | filed 2017 - 2025 |
| Perry Gregory D | Director | filed 2018 - 2025 |
| Koven Andrew I | Director | filed 2017 - 2025 |
| Rosen Howard B | Director | filed 2017 - 2025 |
| Myers C. Daniel | Director | filed 2021 - 2025 |
| Farid Marjan | Director | filed 2022 - 2025 |
| Blumenkranz Mark S. | Director | filed 2021 - 2024 |
| Paull Robert Bradley | Director | filed 2017 - 2022 |
| RA Capital Healthcare Fund LP | Director | filed 2017 - 2022 |
| RA Capital Management, LLC | Director | filed 2017 - 2022 |
| Kolchinsky Peter | Director | filed 2017 - 2022 |
| Shah Rajeev M. | Director | filed 2017 - 2022 |
| Grunberg Gregory | Director | filed 2017 - 2021 |
| Langer Robert | Director | filed 2017 - 2018 |
| Hill Paulina | Director | filed 2017 - 2018 |
| Tepper Robert I | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Brazzell Romulus K | SEE REMARKS | filed 2017 - 2025 |
| Reumuth Mary | Chief Financial Officer | filed 2017 - 2025 |
| Kharabi Darius | CHIEF BUSINESS OFFICER | filed 2021 - 2025 |
| Trachtenberg Eric | See Remarks | filed 2018 - 2024 |
| Chen Hongming | Chief Scientific Officer | filed 2017 - 2021 |
| Larussa Michele | Sr. VP, Regulatory and Quality | filed 2017 - 2018 |
| Mcdermott Charles Douglas | President and Chief Bus. Off. | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.